Search
Showing results for "lung disease preterm"
New research from the Wal-yan Respiratory Research Centre points to a more accurate set of warning signs that can flag declining lung function years before it becomes serious.
Children born preterm have impaired lung function and altered lung structure. However, there are conflicting reports on how preterm birth impacts aerobic exercise capacity in childhood. We aimed to investigate how neonatal history and a diagnosis of bronchopulmonary dysplasia (BPD) impact the relationship between function and structure of the lung, and aerobic capacity in school-aged children born very preterm.
Lung function trajectories are impaired in survivors of very preterm birth
Small airway and lung parenchymal abnormalities frequently occur following preterm birth but are commonly missed by spirometry. Static lung volumes, diffusing capacity of the lung for carbon monoxide (D LCO) and oscillometry provide a more precise characterisation of these conditions. We hypothesised that differences in these measures exist between individuals born preterm and at term and we aimed to systematically review the literature to identify and quantify these differences in lung function.
Analysis of worldwide research shows that despite advances in neonatal care, preterm babies have lower lung function throughout their life.
To obtain comprehensive data on lung structure and function in mid-childhood from survivors of preterm birth.
This research project will investigate the traits of preterm lung disease, looking into the long-term lung health of children born preterm, aiming to identify traits that could help guide better treatments in the future.
To assess whether lung volume and ventilation inhomogeneity in preterm infants at 15-18 months corrected age
Natasha, who is a participant in the West Australian Lung Health in Prematurity (WALHIP) study, this week became the first person to receive a lung health assessment using new state-of-the-art lung function testing equipment at Perth Children’s Hospital.
A new study has found a common asthma drug is effective for some very premature babies who go on to suffer from lung complications.